NEW YORK (GenomeWeb News) – Illumina and Agilent have entered into a non-exclusive co-marketing agreement focused on researchers conducting targeted resequencing.

The firms jointly announced today that they will co-market Agilent's SureSelect Target Enrichment System with Illumina's Genome Analyzer. They said the combination will provide researchers with a method for efficiently resequencing specific regions of interest in the genome and will enable researchers to conduct studies that otherwise would not be feasible.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.